Share >  
Share
Share on Tumblr

Anti Ulcer Drug

News »

   latest by relevance
7% anti-malarial drugs sold in India fake: Study
May 23, 2012 at 13:07 | Source: IBNLive.com
A new study by UK-based medical journal Lancet has found that 7% of anti-malarial drugs tested in India are of poor quality and many are fake. The study goes on to say that 1 in every 3 anti-malarial drugs sold in southeast Asia are also fake.
Top 10 medical/health iOS apps
May 18, 2012 at 09:37 | Source: Tech2.com
When it comes to medical/health apps, weight loss and pregnancy applications seem all the rage. However, there is, of course, more to your health than losing
Cancer drug wars! Cipla slashes prices
May 04, 2012 at 13:45 | Source: CNBC-TV18
It's a drug war, but with a difference and it's been kicked off by Cipla. CNBC TV18's Archana Shukla reports that country's second largest drug firm has slashed prices of three of its key cancer drugs by more than half, making cancer medication costs come down by over 50%.
Cipla launches anti-malarial drug in India
Apr 25, 2012 at 14:08 | Source: CNBC-TV18
In an interview to CNBC-TV18, YK Hamied, chairman and managing director of Cipla says, the company is launching an anti-malarial drug in India. "Today, being the World Malaria day, we are launching a new combination drug along with our partners who are based in Geneva called DNDI," he asserts.
Anti-cholesterol statins don't reduce melanoma risk: Study
Apr 23, 2012 at 08:00 | Source: Reuters
Despite earlier indications that people taking cholesterol-lowering statins might have a reduced risk of developing melanoma, a study of thousands of women found that the popular drugs do nothing to prevent the deadly skin cancer.
Eyeing 18-20% growth in domestic market in FY13: Ipca Labs
Apr 20, 2012 at 11:40 | Source: CNBC-TV18
Exectuive director of Ipca Labs AK Jain told CNBC-TV18 that Ipca Lanbs aims to grow by 18-20% in the domestic market in FY13.

Videos »
Cancer drug wars! Cipla slashes prices
Cipla launches anti-malarial drug in India
Eyeing 18-20% growth in domestic market in FY13: Ipca Labs
Novo Nordisk bets on blockbuster drug to retain top spot
Pfizer's Lipitor to go off-patent: Will Ranbaxy cash-in?
more »

Photos »

  /  
Interact & exchange stock tips & market info »

Web Messenger

Platinum Member

108001 Followers

Sun Pharma  

Source:Business Standard - Wyeth, a Pfizer group company, recently sla...

2.22 PM Mar 16th

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window